Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABIGATRAN ETEXILATE Cause Asthenia? 586 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 586 reports of Asthenia have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 1.6% of all adverse event reports for DABIGATRAN ETEXILATE.

586
Reports of Asthenia with DABIGATRAN ETEXILATE
1.6%
of all DABIGATRAN ETEXILATE reports
59
Deaths
354
Hospitalizations

How Dangerous Is Asthenia From DABIGATRAN ETEXILATE?

Of the 586 reports, 59 (10.1%) resulted in death, 354 (60.4%) required hospitalization, and 44 (7.5%) were considered life-threatening.

Is Asthenia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 586 reports have been filed with the FAERS database.

What Other Side Effects Does DABIGATRAN ETEXILATE Cause?

Gastrointestinal haemorrhage (4,081) Cerebrovascular accident (2,175) Fall (1,786) Ischaemic stroke (1,581) Anaemia (1,412) Haemorrhage (1,324) Death (1,025) Rectal haemorrhage (964) Cerebral haemorrhage (946) Upper gastrointestinal haemorrhage (861)

What Other Drugs Cause Asthenia?

ADALIMUMAB (9,797) LENALIDOMIDE (8,192) METHOTREXATE (6,269) ETANERCEPT (5,546) RITUXIMAB (5,489) PREDNISONE (4,794) TOCILIZUMAB (3,898) INFLIXIMAB (3,729) LEVOTHYROXINE (3,694) SACUBITRIL\VALSARTAN (3,667)

Which DABIGATRAN ETEXILATE Alternatives Have Lower Asthenia Risk?

DABIGATRAN ETEXILATE vs DABRAFENIB DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB DABIGATRAN ETEXILATE vs DACARBAZINE DABIGATRAN ETEXILATE vs DACLATASVIR DABIGATRAN ETEXILATE vs DACLIZUMAB

Related Pages

DABIGATRAN ETEXILATE Full Profile All Asthenia Reports All Drugs Causing Asthenia DABIGATRAN ETEXILATE Demographics